Position in NVS
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$78,360
+$1,985 QoQ
Shares Held
500
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#1,400
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026First PREMIER Bank holds $19,058,988 across 11 Drug Manufacturers - General names. NVS ranks #10 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
36,024 | $9,149,013 | |
| 2 | AMGN |
Amgen Inc
|
8,903 | $3,223,954 | |
| 3 | MRK |
Merck & Co., Inc.
|
21,539 | $2,767,761 | |
| 4 | ABBV |
AbbVie Inc.
|
6,697 | $1,685,232 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
5,692 | $719,126 | |
| 6 | LLY |
ELI LILLY & Co
|
538 | $645,292 | |
| 7 | PFE |
Pfizer Inc
|
15,632 | $376,417 | |
| 8 | GSK |
GSK plc
|
4,433 | $232,377 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $78,360 | 500 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $76,375 | 500 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $68,935 | 500 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $69,634 | 543 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $60,505 | 500 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $55,740 | 500 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $114,339 | 1,175 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $162,178 | 1,410 | Shares | Sole | 2024-10-08 | |
| 2024-06-30 | $116,041 | 1,090 | Shares | Sole | 2024-07-17 | |
| 2024-03-31 | $105,435 | 1,090 | Shares | Sole | 2024-04-12 | |
| 2023-12-31 | $110,057 | 1,090 | Shares | Sole | 2024-01-17 | |
| 2023-09-30 | $111,027 | 1,090 | Shares | Sole | 2023-10-16 | |
| 2023-06-30 | $120,082 | 1,190 | Shares | Sole | 2023-07-13 | |
| 2023-03-31 | $169,280 | 1,840 | Shares | Sole | 2023-04-10 | |
| 2022-12-31 | $166,924 | 1,840 | Shares | Sole | 2023-01-17 | |
| 2022-09-30 | $139,857 | 1,840 | Shares | Sole | 2022-10-20 | |
| 2022-06-30 | $147,081 | 1,740 | Shares | Sole | 2022-07-26 | |
| 2022-03-31 | $163,653 | 1,865 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $180,625 | 2,065 | Shares | Sole | 2022-01-19 | |
| 2021-09-30 | $168,875 | 2,065 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $188,410 | 2,065 | Shares | Sole | 2021-07-14 | |
| 2021-03-31 | $176,516 | 2,065 | Shares | Sole | 2021-04-12 | |
| 2020-12-31 | $194,997 | 2,065 | Shares | Sole | 2021-01-12 | |
| 2020-09-30 | $179,572 | 2,065 | Shares | Sole | 2020-10-06 | |
| 2020-06-30 | $180,357 | 2,065 | Shares | Sole | 2020-07-07 | |
| 2020-03-31 | $170,258 | 2,065 | Shares | Sole | 2020-04-08 | |
| No filing history on record for this holder in this stock. | ||||||